HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Medicis

This article was originally published in The Rose Sheet

Executive Summary

Medicis: Mitchell Wortzman, PhD, to senior VP-research and development, reporting to Medicis Chairman and CEO Jonah Shacknai. Wortzman, who formerly served as Neutrogena Dermatologics division president, will head up research on "innovative" skin care treatments for physicians and patients, the company said. Medicis markets a range of dermatological cosmetics and skin care products through its Tx Systems division. The company recently signed an agreement with Abbott Labs, manufacturer of Ross Labs' Selsun Blue, to market a new skin care product. For the fiscal year ended June 30, the company reported sales growth of 62.6% to $41.2 mil. Earnings for the 12 months more than doubled to $17.3 mil...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel